Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00712543 · ClinicalTrials.gov registry record · Phase 4
A Preference Study Comparing Kristalose® and Liquid Lactulose
A Phase 4 study, sponsored by Cumberland Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00712543 is a Phase 4 study that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 50 participants.
The verdict
NCT00712543, a Phase 4 study, has completed, sponsored by Cumberland Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study will evaluate whether patients have an overall preference for Kristalose® or liquid lactulose based on taste, consistency, and portability.
Interventions
- DRUG lactulose (Kristalose®)
- DRUG liquid lactulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-06 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00712543
The ClinicalTrials.gov registry entry for NCT00712543 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cumberland Pharmaceuticals, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lactulose (Kristalose®) is the first listed.
NCT00712543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00712543 about?
NCT00712543 is a clinical study titled "A Preference Study Comparing Kristalose® and Liquid Lactulose". This study will evaluate whether patients have an overall preference for Kristalose® or liquid lactulose based on taste, consistency, and portability.
What is the current status of trial NCT00712543?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2009-06. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00712543?
The interventions under investigation include: lactulose (Kristalose®) (DRUG), liquid lactulose (DRUG).
Who is sponsoring clinical trial NCT00712543?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.